Infectious disease and pandemic response
3 European H2020 organizations list this as part of their work — 2 as their primary capability.
Most active in this area
- SERVICIO MADRILENO DE SALUD
Madrid's regional health service — a major European clinical trial site and patient recruitment hub across 67 H2020 health research projects.
“Rapid pivot to COVID-19 research visible in recent keywords (covid-19, sars-cov-2, resilience), plus antibiotic resistance work in PLASREVOLUTION and FAST-bact.”
ES67 projects - HOSPICES CIVILS DE LYON
Major French university hospital contributing clinical trials, patient cohorts, and biobanks to European health research across infectious disease, oncology, and neurology.
“Participated in EU-RESPONSE (pandemic preparedness platform trials), I-MOVE-COVID-19, HAP2 (nosocomial infections), and ImmunoSep (sepsis immunotherapy).”
PrimaryFR16 projects - FUNDACION PARA LA INVESTIGACION BIOMEDICA DEL HOSPITAL UNIVERSIATRIO LA PAZ
Madrid university hospital research foundation providing clinical trial sites and patient cohorts to European health consortia in infectious disease, chronic conditions, and rare diseases.
“Participated in COVID-19 drug repurposing (CARE), pandemic preparedness networks (EU-RESPONSE), vaccine trial acceleration (VACCELERATE), and tuberculosis regimen development (ERA4TB).”
PrimaryES12 projects